Question 1

How do antidepressant drugs work to relieve depression symptoms?

Accepted Answer

Antidepressant drugs alleviate depression by enhancing neurotransmission in the brain, modulating the balance of neurotransmitters involved in mood regulation. They work through various mechanisms, such as blocking the reuptake of serotonin, norepinephrine, or both, or inhibiting monoamine metabolism. This enhanced and prolonged neurotransmitter activity helps restore normal mood function.

Question 2

What are the main differences between SSRIs and SNRIs?

Accepted Answer

SSRIs block the reuptake of serotonin only, while SNRIs inhibit the reuptake of both serotonin and norepinephrine. SNRIs were developed to improve overall treatment response compared to SSRIs by targeting two mood-regulating neurotransmitters simultaneously. Both are second-generation agents commonly prescribed for depression and anxiety disorders.

Question 3

Why are tricyclic antidepressants and MAOIs less commonly used today?

Accepted Answer

Tricyclic antidepressants and monoamine oxidase inhibitors are potent but exhibit significant toxicity and serious side effects. Both drug categories are infrequently used as first-line treatments due to these safety concerns and potential drug interactions. However, TCAs continue to play a role in treating specific pain conditions and insomnia cases.

Question 4

How do serotonin receptor antagonists differ from reuptake inhibitors?

Accepted Answer

Serotonin receptor antagonists block the 5HT2 family of receptors rather than inhibiting neurotransmitter reuptake. These agents effectively target specific receptor sites and are particularly useful for treating insomnia. This mechanism differs fundamentally from SSRIs and SNRIs, which work by preventing neurotransmitter reabsorption.

Question 5

What conditions beyond depression can antidepressants treat?

Accepted Answer

Antidepressants effectively manage anxiety disorders, fibromyalgia, and premenstrual dysphoric syndrome. SSRIs and SNRIs are particularly effective for generalized anxiety, panic, social anxiety, and obsessive-compulsive disorders. This broader therapeutic range makes antidepressants valuable for treating multiple mental health and pain-related conditions.

Question 6

How are tricyclic antidepressants classified and what do they target?

Accepted Answer

Tricyclic antidepressants are first-generation agents that primarily block transporters responsible for catecholamine reuptake. They also affect histamine, acetylcholine, and adrenergic receptors, contributing to their broad pharmacological effects. Understanding their multiple receptor interactions is important for predicting side effects and clinical outcomes.

Question 7

What approach is used for treatment-resistant depression?

Accepted Answer

Treatment-resistant depression is addressed through combination therapy using atypical antipsychotics with SSRIs or SNRIs. This augmentation strategy enhances therapeutic efficacy when standard antidepressant monotherapy proves insufficient. The combination approach represents an important clinical option for patients who do not respond to conventional antidepressant treatment alone.

Leki przeciwdepresyjne: Przegląd

Browse More Videos